My group studies the pathobiology of leukemia and inherited bleeding disorders. Mutated epigenetic modifiers, transcription factors and ubiquitin ligases are studied in depth to identify new targets for precision medicine.
Bert van der Reijden is Associate Professor at the Laboratory of Hematology, Department of Laboratory Medicine. He is chair of the RIMLS PhD Programme committee.
<< go back